CD40 expression on graft infiltrates and parenchymal CD154 (CD40L) induction in human chronic renal allograft rejection
- PMID: 10201021
- DOI: 10.1046/j.1523-1755.1999.00379.x
CD40 expression on graft infiltrates and parenchymal CD154 (CD40L) induction in human chronic renal allograft rejection
Abstract
Background: CD40-CD154 (CD40L) costimulatory signaling plays a pivotal role in the effector mechanisms of transplant graft rejection. In animal models, CD40-CD154 blockade induces long-term graft acceptance concurrent with an absence of chronic rejection (CR) lesions. Given the critical importance of CD40-CD154 interactions in the development of chronic transplant allograft rejection, the relevance of in situ CD40 and CD154 expression was assessed in human chronic renal allograft rejection.
Methods: The expression of CD40, CD154, CD68, and T-cell receptor (TCR)alpha/beta was analyzed by immunohistochemistry. Serial cryostat sections of snap-frozen core renal allograft biopsies were obtained from 30 renal transplant patients. Biopsy specimens received diagnoses of CR (N = 23) according to the Banff classification and were compared with controls (N = 7) consisting of stable allografts and normal kidney tissue.
Results: Striking CD40 staining of graft cellular infiltrates (P = 0.016) was observed in renal allografts with CR compared with controls. The CD40+ cellular infiltrates in CR were predominantly TCR alpha/beta + T cells and some CD68+ macrophages. These findings were contrasted by the low-level CD40 expression detected in glomeruli and tubules of CR and controls. However, glomerular induction of CD154 was observed in CR allografts (P = 0.028) as compared with controls. CD154 immunoreactivity was demonstrated on glomerular endothelial, epithelial, and mesangial cells. Moderate CD154 expression was detected on tubular epithelial cells, and only weak CD154 immunoreactivity was observed on the infiltrates in isolated CR cases.
Conclusion: In human chronic renal allograft rejection, CD40 is expressed on graft-infiltrating cells of the T cell and macrophage compartments. CD154 expression is induced on glomerular and tubular epithelial cells during CR, demonstrating another novel source of CD154 expression. The data substantiate the potential contributory role of an interaction between CD40+ graft-destructive effector T cells and macrophages with CD154+ renal allograft parenchymal cells in the development of chronic renal allograft rejection.
Similar articles
-
The Inhibition of CD40/CD154 Costimulatory Signaling in the Prevention of Renal Transplant Rejection in Nonhuman Primates: A Systematic Review and Meta Analysis.Front Immunol. 2022 Apr 7;13:861471. doi: 10.3389/fimmu.2022.861471. eCollection 2022. Front Immunol. 2022. PMID: 35464470 Free PMC article.
-
CD40L (CD154) expression in human liver allografts during chronic ductopenic rejection.Liver Transpl Surg. 1999 Jan;5(1):1-7. doi: 10.1002/lt.500050108. Liver Transpl Surg. 1999. PMID: 9873085
-
CD40 and CD40 ligand (CD154) are coexpressed on microvessels in vivo in human cardiac allograft rejection.Transplantation. 1997 Dec 27;64(12):1765-74. doi: 10.1097/00007890-199712270-00025. Transplantation. 1997. PMID: 9422418
-
[Evaluation of the rate of progression of chronic renal transplant rejection using the proliferating cell nuclear antigen ].Srp Arh Celok Lek. 2002 May-Jun;130(5-6):159-64. doi: 10.2298/sarh0206159s. Srp Arh Celok Lek. 2002. PMID: 12395435 Serbian.
-
Central role for CD40/CD40 ligand (CD154) interactions in transplant rejection.Pediatr Transplant. 1998 Feb;2(1):6-15. Pediatr Transplant. 1998. PMID: 10084754 Review.
Cited by
-
Blockade of CD40-TRAF2,3 or CD40-TRAF6 is sufficient to inhibit pro-inflammatory responses in non-haematopoietic cells.Immunology. 2015 Jan;144(1):21-33. doi: 10.1111/imm.12361. Immunology. 2015. PMID: 25051892 Free PMC article.
-
Cell-cell contacts with epithelial cells modulate the phenotype of human macrophages.Inflammation. 2001 Aug;25(4):241-6. doi: 10.1023/a:1010975804179. Inflammation. 2001. PMID: 11580100
-
Effect of CD40 and sCD40L on renal function and survival in patients with renal artery stenosis.Hypertension. 2013 Apr;61(4):894-900. doi: 10.1161/HYPERTENSIONAHA.111.00685. Epub 2013 Feb 11. Hypertension. 2013. PMID: 23399713 Free PMC article.
-
Targeted disruption of Cd40 in a genetically hypertensive rat model attenuates renal fibrosis and proteinuria, independent of blood pressure.Kidney Int. 2017 Feb;91(2):365-374. doi: 10.1016/j.kint.2016.08.015. Epub 2016 Sep 28. Kidney Int. 2017. PMID: 27692815 Free PMC article.
-
The Inhibition of CD40/CD154 Costimulatory Signaling in the Prevention of Renal Transplant Rejection in Nonhuman Primates: A Systematic Review and Meta Analysis.Front Immunol. 2022 Apr 7;13:861471. doi: 10.3389/fimmu.2022.861471. eCollection 2022. Front Immunol. 2022. PMID: 35464470 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials